MCL1 is often upregulated in acute myeloblastic leukemia (AML) cells, which are often resistant to treatment with BCL2 inhibitors; however, the administration of an MCL1 inhibitor together with a BCL2 inhibitor leads to apoptosis in AML cells or animal models of AML [7]. The gene discussed is BCL2; the disease is acute myeloid leukemia.